MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Insider Roster

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date

CASHMAN CHRISTOPHER MICHAEL
Chief Executive Officer

Conversion of Exercise of derivative security

Mar 17, 2019

271,423

SMITH EDWARD F
Chief Financial Officer

Sale

May 15, 2019

20,097

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.